Current treatment of multidrug resistant tuberculosis in Ethiopia: an aggregated and individual patients’ data analysis for outcome and effectiveness of the current regimens

BACKGROUND: The programmatic management of Multidrug-resistant tuberculosis (MDR-TB) is entirely based on a WHO recommended long-term, 18–24 month lasting treatment regimen. However, growing evidence shows that low treatment success rate and high rates of adverse events are associated with this regi...

Descripción completa

Detalles Bibliográficos
Autores principales: Eshetie, Setegn, Alebel, Animut, Wagnew, Fasil, Geremew, Demeke, Fasil, Alebachew, Sack, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161354/
https://www.ncbi.nlm.nih.gov/pubmed/30261852
http://dx.doi.org/10.1186/s12879-018-3401-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161354/
https://www.ncbi.nlm.nih.gov/pubmed/30261852
http://dx.doi.org/10.1186/s12879-018-3401-5

Ejemplares similares